Measles outbreak in an orphanage: HIV-Infected children on antiretroviral therapy are still at risk

Pediatric Infectious Disease Journal

Volumn 29, Issue 2, 2010, Pages 167-169

  Aurpibul, Linda ^a   Puthanakit, Thanyawee ^a   Kanjanavanit, Suparat ^b   Sirisanthana, Thira ^a   Sirisanthana, Virat ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Chiang Mai Provincial Health Office   (Thailand)

Author keywords

Children; HIV; Measles; Outbreak; Vaccination

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; NONHUMAN; ORPHANAGE; PRIORITY JOURNAL; THAILAND;

EID: 75949121330     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181b99e15     Document Type: Article

References (9)

1. American Academy of Pediatrics. Immunization in special clinical circumstances. In: Pickering LK, Baker CJ, Long SS, et al, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:71-85.
2. al-Attar I, Reisman J, Muehlmann M, et al. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1995;14:149-151.
3. Aurpibul L, Puthanakit T, Siriaksorn S, et al. Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy. HIV Med. 2006;7:467-470.
4. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children 2006:15. Available at:http://www.who.int/hiv/pub/guidelines/hivstaging/en/ index.html. Accessed May 8, 2009.
5. Aurpibul L, Puthanakit T, Sirisanthana T, et al. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clin Infect Dis. 2007; 45:637-642. (Pubitemid 47328647)
6. American Academy of pediatrics. Measles. In: Pickering LK, Baker CL, Long SS, et al, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:441-452.
7. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Sustained immunologic and virologic efficacy after 4 years of highly active antiretroviral therapy in human immunodeficiency virus-infected children in Thailand. Pediatr Infect Dis J. 2007;26:953-956.
8. Puthanakit T, Aurpibul L, Sirisanthana T, et al. Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thai HIV-infected children aged 2 years or less. Pediatr Inf Dis J. 2009;28: 246-248.
9. Farquhar C, Wamalwa D, Selig S, et al. Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre-and post-highly active antiretroviral therapy and revaccination. Pediatr Infect Dis J. 2009;28:295-299.